Video modal
popup modal
The MHICC is now Seriant !
The Montreal Health Innovations Coordinating Center (MHICC) is now Seriant.
Our new name reflects a bold step forward— expanding beyond cardiology and embracing innovations in clinical trials with a global reach.
While our identity has evolved, our commitment to operational excellence, client satisfaction, and quality remains the same.
Optimizing Clinical Trials with Precision Medicine: A Candid Expert Discussion
June 16, 2025
Two recognized experts from one of the world's largest precision medicine studies offer their perspective and answer the most pressing questions about using precision medicine to optimize clinical trials within the regulatory landscape.
SPEAKERS
Jean-Claude Tardif, MD, FRCPC, FCCS, FACC, FAHA, FESC, FCAHS
Director, Montreal Heart Institute Research Center
Scientific Director, Seriant
Dr. Jean-Claude Tardif is a cardiologist and Director of the Research Center at the Montreal Heart Institute, Scientific Director of Seriant, and Professor of Medicine at the University of Montreal. A global leader in precision medicine and translational research, he holds the Canada Research Chair in Personalized Medicine and has authored over 840 publications. He has led landmark cardiovascular trials and founded the UoM Pharmacogenomics Center and the Center of Excellence in Personalized Medicine advancing genomics and precision medicine.
Marie-Pierre Dubé, PhD
Director of the Beaulieu-Saucier Pharmacogenomics Centre
Montreal Heart Institute
Marie-Pierre Dubé, PhD, is recognized for her contributions to the precision medicine field. She is the Director of the Beaulieu-Saucier Pharmacogenomics Centre at the Montreal Heart Institute and a Full Professor at Université de Montréal. She teaches genetic epidemiology and supervises graduate students in the Faculty of Medicine. Her research focuses on pharmacogenomics and precision medicine in clinical trials. Her research is supported by the Canada Research Chair program.
